UK markets close in 3 hours 1 minute

  • FTSE 100

    7,020.74
    +37.24 (+0.53%)
     

  • FTSE 250

    22,535.50
    +63.46 (+0.28%)
     

  • AIM

    1,251.58
    +3.45 (+0.28%)
     

  • GBP/EUR

    1.1516
    +0.0005 (+0.05%)
     

  • GBP/USD

    1.3797
    +0.0013 (+0.09%)
     

  • BTC-GBP

    44,158.93
    -1,275.28 (-2.81%)
     

  • CMC Crypto 200

    1,355.19
    -25.76 (-1.87%)
     

  • S&P 500

    4,170.42
    +45.76 (+1.11%)
     

  • DOW

    34,035.99
    +305.10 (+0.90%)
     

  • CRUDE OIL

    63.53
    +0.07 (+0.11%)
     

  • GOLD FUTURES

    1,781.50
    +14.70 (+0.83%)
     

  • NIKKEI 225

    29,683.37
    +40.68 (+0.14%)
     

  • HANG SENG

    28,969.71
    +176.57 (+0.61%)
     

  • DAX

    15,418.92
    +163.59 (+1.07%)
     

  • CAC 40

    6,262.92
    +28.78 (+0.46%)
     
Property:

UK second homes surge to record high of 495,000

The number of second homes in Britain rose by 30% prior to the pandemic

Change of ownership / shares in RIAS A/S

Rias A/S

In accordance with the Capital Markets Act section 30, cf. section 38, we can hereby inform that SmallCap Danmark A/S has sold all their shares in RIAS A/S and therefore do not own more shares in RIAS A/S.


Latest stories

  • Derek Chauvin Murder Trial: What Brits Need To Know About The Case

    The ex-officer is accused of killing George Floyd by kneeling on his neck last year. Here's what we've learnt and what happens next.

  • 'The Falcon and the Winter Soldier' Episode 5 recap: Easter eggs, seven talking points and THAT mid-credits scene

    There were plenty of surprises in the penultimate episode of the Marvel show on Disney+.

  • First Dates star opens up about exhausting realities of dating while trans

    A trans man opened up about the stigma he faces on the dating scene from people who have a “small town mentality” on First Dates Ireland.

  • Borat Trolls Donald Trump's Election Lies In Never-Before-Seen Footage Teaser

    Sacha Baron Cohen's alter ego returns in a new show featuring behind-the-scenes footage from "Borat 2."

  • Clean crude? Oil firms use offsets to claim green barrels

    In January, Occidental Petroleum announced it had accomplished something no oil company had done before: It sold a shipload of crude that it said was 100% carbon-neutral. While the two-million-barrel cargo to India was destined to produce more than a million tons of planet-warming carbon over its lifecycle, from well to tailpipe, the Texas-based driller said it had completely offset that impact by purchasing carbon credits under a U.N.-sponsored program called CORSIA. Carbon credits are financial instruments generated by projects that reduce or avert greenhouse-gas emissions such as mass tree plantings or solar power farms.

  • Global Virtual Clinical Trials Market (2020 to 2026) - by Study Type, Indication and Region - ResearchAndMarkets.com

    The "Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

  • Flexible rail season tickets will offer 15% discount – report

    Passengers in England will be able to purchase French-style carnet tickets from June, it has been reported.

  • Russia hits out at UK support for US sanctions over hacking

    Russia hits out at UK support for US sanctions over hacking. UK’s release of details on Russian cyber-espionage ‘nothing more than an attempt to play along with’ US

  • 2021 Insights on the Pain Therapeutics Global Markets - Advances in Pharmacogenomics and Pharmacogenetics are Enabling the Development of Personalized Approaches to Pain Management

    Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "Pain Therapeutics - Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report describes the latest concepts of pathomechanisms of pain as a basis for the management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brain imaging.Most of the currently used analgesic drugs fall into the categories of opioids and nonsteroidal anti-inflammatory drugs such as COX-2 inhibitors. Non-opioid analgesics include ketamine, an N-methyl-D-aspartate receptor antagonist. Adjuvant analgesics include antidepressants and antiepileptic drugs used for the treatment of neuropathic pain. Management of pain is multidisciplinary and includes both pharmacological and non-pharmacological methods such as acupuncture, transcutaneous electrical nerve stimulation and surgery. Various pain syndromes require different approaches in management, for example, the main category of drugs for migraine are triptans such as sumatriptan.Drug delivery is an important consideration in pain treatment. Controlled release preparations provide a steady delivery of analgesics. Well-known non-injection methods such as transdermal, pulmonary, and intranasal applications have been used. Topical analgesics and local anesthetics are also available. Devices such as implanted pumps are used for the delivery of drugs such as opioids intrathecally (introduction into spinal subarachnoid space by lumbar puncture) in patients with cancer pain.The wide variety of drugs in development includes opioid receptor ligands, bradykinin antagonists, mPGES-1 inhibitors, glutamate receptor antagonists, substance P and neurokinin receptor antagonists, norepinephrine transporter inhibitors, P2X2 neuron receptor antagonists and nitric oxide-based analgesics. A number of cannabinoids are also in development for pain. Fish-derived tetrodotoxin was initially focused on an indication of opiate addiction withdrawal but is found to have an analgesic action as well. Cone shells contain therapeutically useful peptides including the conotoxins, and one such peptide, ziconotide, has been approved. Various cell and gene therapies are also being developed for the management of pain.Advances in molecular and biological techniques are markedly advancing our understanding of pain. Understanding the pathophysiology of pain is an important factor in the discovery of rational therapies for pain. Advances in pharmacogenomics and pharmacogenetics are enabling the development of personalized approaches to the management of pain.Over 500 companies have been identified to be involved in developing or marketing pain therapeutics and 173 of these are profiled in the report along with 156 collaborations. These are a mix of pharmaceutical companies and biotechnology companies.The worldwide analgesic markets were analyzed for the year 2020 and projected to 2030. Calculations are based on the epidemiology of various painful conditions and the development of analgesic drugs and devices. Unfulfilled needs for analgesics are identified and strategies are outlined to develop markets for analgesic drugs. The report is supplemented with 77 tables, 25 figures, and 600 selected references to the literature.The report contains information on the following: Basic aspects of painAssessment of painPharmacology of painManagement of painDrug delivery for painDrug development for painPain marketsFuture of pain therapeuticsCompanies involved pain therapeutics Key Topics Covered: Executive Summary 1. Basic Aspects of Pain 2. Assessment of Pain and Analgesics 3. Pharmacotherapy of Pain 4. Management of Pain 5. Drug Delivery for Pain 6. Drug Development for Pain 7. Safety, Regulatory and Legal issues of pain management 8. Pain Markets 9. Future of Pain Therapeutics 10. Companies Involved in Pain Therapeutics 11. References For more information about this report visit https://www.researchandmarkets.com/r/uom2uz CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Anesthetic Drugs Market Research Report by Drug Type, by Route of Administration, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

    Anesthetic Drugs Market Research Report by Drug Type (General Anesthesia Drugs and Local Anesthesia Drugs), by Route of Administration (Inhalation and Injection), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, April 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Anesthetic Drugs Market Research Report by Drug Type, by Route of Administration, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06063102/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Anesthetic Drugs Market is expected to grow from USD 4,198.28 Million in 2020 to USD 5,489.67 Million by the end of 2025.2. The Global Anesthetic Drugs Market is expected to grow from EUR 3,681.13 Million in 2020 to EUR 4,813.44 Million by the end of 2025.3. The Global Anesthetic Drugs Market is expected to grow from GBP 3,272.53 Million in 2020 to GBP 4,279.16 Million by the end of 2025.4. The Global Anesthetic Drugs Market is expected to grow from JPY 448,062.86 Million in 2020 to JPY 585,886.89 Million by the end of 2025.5. The Global Anesthetic Drugs Market is expected to grow from AUD 6,096.46 Million in 2020 to AUD 7,971.73 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Anesthetic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Drug Type, the Anesthetic Drugs Market studied across General Anesthesia Drugs and Local Anesthesia Drugs. Based on Route of Administration, the Anesthetic Drugs Market studied across Inhalation and Injection. Based on Application, the Anesthetic Drugs Market studied across Cosmetic Surgery, Dental Surgery, General Surgery, and Plastic Surgery. Based on Geography, the Anesthetic Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Anesthetic Drugs Market including Abbott Laboratories, AbbVie Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG, Claris Lifesciences Limited, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Hospira, Inc, Maruishi Pharmaceutical Co., Ltd., Mylan NV, Pacira Pharmaceuticals, Inc., Paion UK Ltd, Pfizer Inc., Piramal Enterprises LTD, Septodont Healthcare India Pvt. Ltd., Slayback Pharma LLC, Teva Pharmaceutical Industries Limited, and Troikaa Pharmaceuticals Ltd. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anesthetic Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Anesthetic Drugs Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anesthetic Drugs Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anesthetic Drugs Market?4. What is the competitive strategic window for opportunities in the Global Anesthetic Drugs Market?5. What are the technology trends and regulatory frameworks in the Global Anesthetic Drugs Market?6. What are the modes and strategic moves considered suitable for entering the Global Anesthetic Drugs Market?Read the full report: https://www.reportlinker.com/p06063102/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Canine coronavirus causes 'severe vomiting' in dogs, study reveals

    The infection could become seasonal, scientists have warned.

  • Insights on the North America Ginseng Extracts Market to 2026 - Featuring Clariant, Orkla and Sinochem Group Among Others - ResearchAndMarkets.com

    The "North America Ginseng Extracts Market By Application (Pharmaceuticals, Food & Beverages, Dietary Supplements and Cosmetics & Personal Care), By Form (Powder and Liquid), By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

  • Procter & Gamble Earnings: What to Watch

    Procter & Gamble (NYSE: PG) stock is limping into its upcoming earnings report, meaning many investors believe its recent growth spike was just a temporary lift brought on by the global pandemic. Investors are bracing for a growth slowdown starting this quarter as the company begins to go up against extreme demand surges from the pantry-stocking phase of the pandemic last year.

  • Ministers accuse DUP of ‘obstructing’ north-south relations

    Infrastructure Minister Nichola Mallon said a north-south transport meeting was unable to proceed due to no unionist minister being available.

  • Watch Powerlifter Leah Reichman Set a New World Record with a 399.1kg Squat

    The new WR was set in the women's equipped 90+ kilogram class

  • Global Digital Asset Management Market Report 2021-2026: Focus on Brand Asset Management Systems, Library Asset Management Systems & Production Asset Management Systems

    Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "Digital Asset Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global digital asset management market reached a value of US$ 3.88 Billion in 2020. Looking forward, the global digital asset management market to exhibit strong growth during 2021-2026. Digital asset management (DAM) refers to a software-based solution that is used by organizations for quick storage, retrieval and utilization of digital assets. These assets usually include processed data files, engineering blueprints, text documents, web pages, audios, videos and graphics. DAM solutions enable the authorized user to retrieve, review, edit and share data through a centralized interface. Apart from this, they automate workflow, manage permissions through copyright functionalities and streamline cloud experience for users. Owing to these benefits, they find extensive application across various industries, including banking, financial services and insurance (BFSI), retail, manufacturing, information technology (IT), education, etc.The emerging trend of digitization, along with the increasing adoption of cloud-based services across the globe, is among the key factors driving the growth of the market. Owing to the growing demand for workflow collaboration and automation, enterprises are increasingly utilizing DAM solutions to maintain transparency of operations, improve digital content and reduce overall operational costs. Furthermore, the increasing organizational focus on digital marketing is providing a boost to the market growth. As consumers are spending more time on various social media platforms, enterprises are employing these solutions to reach the masses, improve customer engagement and integrate analytical tools to understand consumer behavioral patterns. Additionally, cloud-based DAM solutions offer improved access to digital assets, higher scalability and operational speed. As a result, they are gaining rapid preference among consumers across the globe. Other factors, including the integration of artificial intelligence (AI) and extensive research and development (R&D) in the field of information technology (IT), are projected to drive the market further. Competitive Landscape:The competitive landscape of the industry has also been examined with some of the key player being Adam Software, Canto Inc., Celum, Cognizant Technology Solutions, OpenText Corporation, North Plains Systems, Oracle Corporation, QBank, Webdam Inc., Mediabeacon Inc., IBM Corporation, Widen Enterprises Inc., etc.Key Questions Answered in This Report: How has the global digital asset management market performed so far and how will it perform in the coming years?What are the key regional markets?What has been the impact of COVID-19 on the global digital asset management market ?What is the breakup of the market based on the type?What is the breakup of the market based on the component?What is the breakup of the market based on the application?What is the breakup of the market based on the deployment?What is the breakup of the market based on the organization size?What is the breakup of the market based on the end-use sector?What are the various stages in the value chain of the industry?What are the key driving factors and challenges in the market?What is the structure of the global digital asset management market and who are the key players?What is the degree of competition in the market? Key Topics Covered: 1 Preface2 Scope and Methodology2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.4 Market Estimation2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Digital Asset Management Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast6 Market Breakup by Type6.1 Brand Asset Management Systems6.2 Library Asset Management Systems6.3 Production Asset Management Systems7 Market Breakup by Component7.1 Solution7.2 Services7.2.1 Market Trends7.2.2 Major Types7.2.2.1 Consulting7.2.2.2 System Integration7.2.2.3 Support and Maintenance7.2.3 Market Forecast8 Market Breakup by Application8.1 Sales and Marketing8.2 Broadcast and Publishing8.3 Others9 Market Breakup by Deployment9.1 On-premises9.2 Cloud10 Market Breakup by Organization Size10.1 Small and Medium-sized Enterprises10.2 Large Enterprises11 Market Breakup by End-Use Sector11.1 Media and Entertainment11.2 Banking, Financial Services and Insurance (BFSI)11.3 Retail11.4 Manufacturing11.5 Healthcare and Life Sciences11.6 Education11.7 Travel and Tourism12 Market Breakup by Region14 Value Chain Analysis15 Porters Five Forces Analysis16 Competitive Landscape16.1 Market Structure16.2 Key Players16.3 Profiles of Key PlayersFor more information about this report visit https://www.researchandmarkets.com/r/q0swkr CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Seven face prosecution for alleged mistreatment at NI psychiatric hospital

    It is understood the seven are staff members at Muckamore Abbey Hospital’s psychiatric intensive care unit.

  • Alternative & Complementary Medicine Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19

    Alternative & Complementary Medicine Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD.New York, April 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Alternative & Complementary Medicine Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06063103/?utm_source=GNW This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Alternative & Complementary Medicine Market is expected to grow from USD 78,472.67 Million in 2020 to USD 132,903.67 Million by the end of 2025.2. The Global Alternative & Complementary Medicine Market is expected to grow from EUR 68,806.33 Million in 2020 to EUR 116,532.46 Million by the end of 2025.3. The Global Alternative & Complementary Medicine Market is expected to grow from GBP 61,168.98 Million in 2020 to GBP 103,597.61 Million by the end of 2025.4. The Global Alternative & Complementary Medicine Market is expected to grow from JPY 8,375,023.22 Million in 2020 to JPY 14,184,189.36 Million by the end of 2025.5. The Global Alternative & Complementary Medicine Market is expected to grow from AUD 113,952.76 Million in 2020 to AUD 192,993.80 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Alternative & Complementary Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Geography, the Alternative & Complementary Medicine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Alternative & Complementary Medicine Market including AmeriCare Physical Therapy, Boiron, Cipla Limited, Columbia Nutritional, LLC, Dabur India Ltd., doTERRA International LLC, First Natural Brands Ltd, Full Motion Physical Therapy, Herb Pharm, LLC, Mountain Rose Herbs, Nature’s Bounty, Nordic Naturals, Novartis AG, PEKANA Naturheilmittel GmbH, Pharmesis International Ltd., Pure Encapsulations, LLC, Rocky Mountain Oils LLC, schwa-medico GmbH, SEIRIN Corporation, The Arya Vaidya Pharmacy (CBE) Ltd., The Himalaya Drug Company, and Weleda AG. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Alternative & Complementary Medicine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Alternative & Complementary Medicine Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Alternative & Complementary Medicine Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Alternative & Complementary Medicine Market?4. What is the competitive strategic window for opportunities in the Global Alternative & Complementary Medicine Market?5. What are the technology trends and regulatory frameworks in the Global Alternative & Complementary Medicine Market?6. What are the modes and strategic moves considered suitable for entering the Global Alternative & Complementary Medicine Market?Read the full report: https://www.reportlinker.com/p06063103/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Greensill to be investigated by Whitehall spending watchdog

    At least three separate parliamentary committees will also launch inquiries

  • International Insider: Sister Earnings Revealed; Farewell Prince Philip; Cannes Caves; Bollywood On Lockdown; BAFTA Verdict

    Happy Friday all, and welcome to the latest edition of International Insider. Jake Kanter with you as usual, as we reflect on another week of international film and television news. I’m on jkanter@deadline.com if you want to write, or my DMs are open on Twitter. And sign up here to get this delivered to your inbox every […]